Hydropic Fetus With Tachycardia at 29 Weeks: Treat In Utero or Deliver?
A fetus at 29 weeks' gestation is referred for tachycardia at 245 bpm. Ultrasound shows ascites, scalp edema, a cardiothoracic area ratio of 0.55, moderate tricuspid regurgitation, and a small pericardial effusion. Doppler interrogation of the superior vena cava and ascending aorta suggests a 1:1 atrioventricular relationship with a short VA interval. The mother is healthy, takes no medications, has a normal ECG, and has no history of palpitations. The obstetric team proposes cesarean delivery tonight for hydrops, and the neonatal team is unsure a bed exists at that gestation. Umbilical artery Doppler findings are normal and the middle cerebral artery peak systolic velocity is normal.
1. What is the likely mechanism of the tachycardia, and how does it change your drug choice?
Read the worked answer
Mechanism A 1:1 AV relationship with a short VA interval is most consistent with atrioventricular re-entry using an accessory pathway, the commonest fetal tachycardia. A long VA interval would suggest atrial flutter or ectopic atrial tachycardia, which changes drug selection. Ventricular tachycardia is effectively excluded by the 1:1 relationship with a short VA interval and normal ventricular function.
Drug choice in the setting of hydrops
- Transplacental digoxin is less effective when the placenta is edematous, because transfer is impaired.
- Flecainide has better reported conversion rates in hydropic fetuses and is a reasonable first-line choice; it requires maternal ECG surveillance (QRS widening), maternal drug-level and electrolyte checks, and avoidance in any maternal structural heart disease. Sotalol is an alternative, and is favored for long-VA/atrial flutter.
- Amiodarone is reserved for refractory cases because of thyroid and neurodevelopmental concerns with prolonged use.
Aim for in utero conversion; expect hydrops to resolve over days to weeks after rhythm control, not immediately.
2. Should this fetus be delivered tonight? Justify your answer.
Read the worked answer
No - delivery should be avoided if possible, but planned for if treatment fails.
Reasons to treat in utero
- At 29 weeks, prematurity plus hydrops carries substantial mortality and morbidity; the NICU bed uncertainty reflects that risk.
- Hydrops here is driven by the arrhythmia, is potentially reversible, and there is no evidence of fetal compromise: umbilical artery Doppler readings are normal, the middle cerebral artery peak velocity is normal (no anemia), and there is no hydrops-related acidemia documented.
When to deliver
- Failure to control the rhythm after adequate trials of therapy, worsening hydrops or fetal hydrops-related compromise, or maternal toxicity.
- If delivery becomes necessary, give antenatal corticosteroids, plan delivery at a center with pediatric cardiology, echocardiography, and ECMO capability, and have a neonatal resuscitation plan for a hydropic infant requiring immediate cardioversion or antiarrhythmic therapy.
Practical plan Admit the mother for rhythm and drug monitoring, daily fetal echocardiography initially, and serial biometry for hydrops. Set explicit triggers for delivery with obstetrics and neonatology in advance.
3. What is the postnatal plan for this infant if conversion occurs before delivery?
Read the worked answer
At birth
- Attend the delivery with neonatal and cardiology teams; obtain a 12-lead ECG and echocardiogram.
- Expect possible Wolff-Parkinson-White pattern, residual ventricular dysfunction, and slow resolution of hydrops over days to weeks; the infant may still need respiratory support and diuresis.
- Monitor continuously for at least 24-48 hours for recurrence; recurrence risk is significant in the first weeks to months.
If tachycardia recurs
- Assess hemodynamic stability; use vagal maneuvers, then synchronized cardioversion for instability, or adenosine for stable narrow-complex tachycardia.
- For maintenance therapy, discuss beta-blockade or flecainide with the family, weighing the risk of recurrence against proarrhythmia.
Counseling Explain that survival is good after successful rhythm control, that follow-up is needed for months, and that the child may need electrophysiology assessment later if pre-excitation persists. Set expectations that hydrops resolution is not instantaneous and that the infant may look puffy and unwell initially.